When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 19 Mar 2025
Last updated: 26 Sep 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • oral numbness
  • dysphagia
  • dysarthria (common)
  • nausea (saxitoxin, tetrodotoxin)
  • vomiting (saxitoxin, tetrodotoxin)
  • diarrhoea (saxitoxin, tetrodotoxin)
  • weakness
  • ataxia/incoordination
  • hypertension (saxitoxin)
  • extreme pain (conotoxin)
  • hypotension or cardiovascular instability

Other diagnostic factors

  • light-headedness/dizziness
  • postural near-syncope/syncope
  • anxiety
  • loss of airway-protective reflexes
  • loss of adequate ventilation
  • hypoxia
  • bradycardia
  • apnoea
  • ventricular dysrhythmias

Risk factors

  • warmer waters
  • shellfish ingestion (saxitoxin)
  • xanthid crab ingestion (saxitoxin)
  • seafood ingestion (tetrodotoxin)
  • handling of blue-ringed octopus (tetrodotoxin)
  • handling of cone snail shells (conotoxin)
  • exposure to toxins in research/laboratory settings
  • bioterrorism

Diagnostic investigations

Investigations to consider

  • pulse oximetry
  • capnography
  • serial pulmonary function tests
  • arterial blood gases
  • chest x-ray
  • CT brain
  • serum electrolytes
  • high-performance liquid chromatography in flesh of seafood

Emerging tests

  • serum/urine toxin analysis

Treatment algorithm

Contributors

Authors

William T. Hurley, MD, MBA, FACEP, FACMT

Emergency Medicine Physician and Medical Toxicologist

Emergency Services Institute and International Operations

The Cleveland Clinic

Cleveland

OH

Disclosures

WTH is the author of a reference cited in this topic.

Jacob A. Lebin, MD

Senior Instructor of Emergency Medicine

Department of Emergency Medicine

Section of Medical Pharmacology and Toxicology

University of Colorado School of Medicine

Aurora

CO

Medical Toxicologist

Rocky Mountain Poison and Drug Safety

Denver

CO

Disclosures

JAL has been provided consulting fees for Purdue Pharma.

Acknowledgements

Dr William T. Hurley and Dr Jacob A. Lebin would like to gratefully acknowledge Dr Arvin Akhavan, a previous contributor to this topic.

Disclosures

AA declares that he has no competing interests.

Peer reviewers

Scott D. Phillips, MD, FACP, FACMT, FAACT

Clinical Faculty

Rocky Mountain Poison and Drug Safety

Denver

CO

Disclosures

SDP declares that he has no competing interests.

Richard S. Weisman, Pharm.D., DABAT, FAACT

Professor of Pediatrics

University of Miami

Miller School of Medicine

Director

Florida Poison Center - Miami

Miami

FL

Disclosures

RSW declares that he has no competing interests.

Nick Buckley, MD, FRACP

Professor of Clinical Pharmacology and Toxicology

University of Sydney

Sydney

Australia

Disclosures

NB declares that he has no competing interests.

Use of this content is subject to our disclaimer